Paid Clinical Trials Nebraska

Discover 659 paid clinical trials in Nebraska. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 659

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder CancerA Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Omaha NE, Wichita KS, Aurora CO, Lakewood COshow 29 more

Code:

NCT06319820

Conditions

Non-Muscle Invasive Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAR-210

Gemcitabine

MMC

Empagliflozin Treatment in Kidney Transplant RecipientsEmpagliflozin Treatment in Kidney Transplant Recipients

Recruiting

Sponsor:

VA Office of Research and Development

Location:

Omaha NE, Iowa City IA, Nashville TN, Pittsburgh PA

Code:

NCT06013865

Conditions

Kidney Transplant

Type 2 Diabetes

Eligibility Criteria

Sex: All

Age: 19+

Healthy Volunteers: Not accepted

Interventions

Empagliflozin

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST)A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST)

Recruiting

PHASE2

PHASE3

Sponsor:

Biogen

Location:

Omaha NE, Denver CO, Saint Louis MO, Rockford ILshow 51 more

Code:

NCT05531565

Conditions

Subacute Cutaneous Lupus Erythematosus

Chronic Cutaneous Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Litifilimab

Placebo

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaThoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Recruiting

PHASE3

Sponsor:

Children's Oncology Group

Location:

Omaha NE, Sioux Falls SD, Kansas City MO, Des Moines IAshow 144 more

Code:

NCT05235165

Conditions

Metastatic Malignant Neoplasm in the Lung

Metastatic Osteosarcoma

Osteosarcoma

Eligibility Criteria

Sex: All

Age: 0 - 50

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Questionnaire Administration

Thoracoscopy

Thoracotomy

Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseSafety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Recruiting

PHASE2

Sponsor:

ReAlta Life Sciences, Inc.

Location:

Omaha NE, Glen Burnie MD, Philadelphia PA, Saint Petersburg FL

Code:

NCT06175065

Conditions

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Eligibility Criteria

Sex: All

Age: 30+

Healthy Volunteers: Not accepted

Interventions

RLS-0071

Placebo

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder CancerTrial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

Recruiting

PHASE3

Sponsor:

Ferring Pharmaceuticals

Location:

Omaha NE, Creve Coeur MO, Mobile AL, Burlingtonshow 7 more

Code:

NCT06510374

Conditions

Intermediate Risk Non-Muscle Invasive Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nadofaragene Firadenovec

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid ArthritisStudy to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Lincoln NE, Kansas City MO, Fort Collins CO, Aurora COshow 77 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults with Soft Tissue Sarcomas (INVINCIBLE-3)A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults with Soft Tissue Sarcomas (INVINCIBLE-3)

Recruiting

PHASE3

Sponsor:

Intensity Therapeutics, Inc.

Location:

Omaha NE, Columbus OH, Toronto, Durham NCshow 4 more

Code:

NCT06263231

Conditions

Sarcoma,Soft Tissue

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

INT230-6

Eribulin

Trabectedin

Pazopanib

Continuous Monitoring and Control of HypoglycemiaContinuous Monitoring and Control of Hypoglycemia

Recruiting

Sponsor:

DexCom, Inc.

Location:

Omaha NE, Topeka KS, Kansas City MO, Des Moines IAshow 20 more

Code:

NCT03340831

Conditions

Diabetes

Eligibility Criteria

Sex: All

Age: 2+

Healthy Volunteers: Not accepted

Interventions

Continuous Glucose Monitoring (CGM)

Harmony TPV Post-Approval StudyHarmony TPV Post-Approval Study

Recruiting

Sponsor:

Medtronic Cardiovascular

Location:

Omaha NE, Aurora CO, Saint Louis MO, Oak Lawn ILshow 17 more

Code:

NCT05077774

Conditions

Congenital Heart Disease

Tetrology of Fallot

RVOT Anomaly

Pulmonary Regurgitation

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Harmony TPV System

Popular cities in Nebraska

Lincoln Bellevue Omaha